Economic Times, Pharma industry urges govt for stable drug pricing policy
The Organisation of Pharmaceutical Producers of India (OPPI), which represents prominent multinational pharma companies, has asked the government for a “predictable” pricing policy for drugs and not to resort to Para 19 of the Drug Pricing Control Order (DPCO) that authorises the regulator to reduce prices significantly in public interest for a period as it deems fit. The National Pharmaceutical Pricing Authority-India’s drug pricing regulator-had earlier invoked Para 19 of DPCO to slash prices of cardiac stents and knee implants to make them affordable.
[Cross-posted with thanks from Public Citizen via the Covid-19-access listserv; WB]